Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20200584
    Veröffentlichungsdatum: 2 Oktober 2020

    Projektträger – zwischengeschaltetes Finanzinstitut

    COUNTERPART(S) TO BE DETERMINED

    Ort

    Beschreibung

    The operation aims at increasing the local manufacturing capacity of active pharmaceutical ingredients (APIs) in sub-Saharan Africa (SSA).

    Ziele

    The operation aims at increasing the local manufacturing capacity of active pharmaceutical ingredients (APIs) in sub-Saharan Africa. The ultimate objective is to improve the availability of pharmaceutical products in the region and to increase the robustness of the pharmaceutical supply chain by reducing dependency on imports.

    Sektor(en)

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 50 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 100 million

    Umweltaspekte

    The overall environmental impact and the residual environmental risks of the operation are unknown at this stage and will be assessed at the appraisal of individual sub-operations. The Bank will require the beneficiaries to ensure that implementation of the sub-projects will be done in accordance with the Bank's environmental and social policy and standards.

    Auftragsvergabe

    The Bank will require that the beneficiaries ensure that the implementation of the sub-operations will be done in accordance with the Bank's Guide to Procurement.

    Projektstatus

    Genehmigt - 11/11/2020

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Regionalvorhaben - Afrika Gesundheit